New Therapy Provides Hope For Spina Bifida

A new therapy could prevent lifelong disability for thousands of babies each year, offering hope before birth to families facing spina bifida. Spina bifida is a condition where the spine doesn’t close properly during early development. The result can be paralysis, bladder or bowel problems and lifelong disability. For decades, treatment began only after birth. Now, a growing movement focuses on starting earlier, inside the womb, to dramatically improve a baby’s future. One of the most promising examples is in utero surgery that combines traditional repair techniques with stem cell therapy.

A New Path For Babies With Spina Bifida

In spina bifida, part of the spinal cord stays exposed inside the womb. That exposure can damage important nerves even before a baby is born. The most severe form can cause paralysis and loss of bladder or bowel control. It often necessitates multiple surgeries throughout life. Traditional surgery after birth can cover and protect the area, but it can’t undo nerve damage that has already happened.

Now, new techniques allow repairs to happen earlier. Performing the repair during pregnancy provides protection sooner, while the spinal cord is still forming. This research exemplifies a broader shift in medicine. Increasingly, clinicians rely on these advanced diagnostic tools to intervene early, using targeted therapies that may fundamentally alter disease progression.

One of the most promising methods combines prenatal surgery with stem cell patches that help protect and heal the spinal cord before birth. This recent approach was the focus of The CuRe Trial. The CuRe results were recently reported in The Lancet. The study’s goal was to strengthen and repair the spinal tissue so that infants can move and develop more normally after birth.

What The CuRe Trial Does Differently

CuRe uses a surgical technique similar to that seen in previous trials. These past methods showed that repairing spina bifida before birth reduces the need for brain shunts and improves motor function. This trial used that process, then added a subsequent step.

Between 19 and 26 weeks of pregnancy, a small patch made from cells collected from donated placentas is placed over the baby’s exposed spinal cord. The patch serves as a natural covering that releases natural growth factors that help nerve cells survive and rebuild damaged tissue. The goal was to determine whether the procedure was safe in humans and whether the same effects might carry over to babies developing in the womb.

Six pregnancies have been completed with this method so far. Every surgery went smoothly, and all babies were delivered safely. No infections or fluid leaks occurred. After birth, brain scans showed that the swelling near the brain had resolved in every case. None of the babies needed an implanted brain shunt, an operation typically required to drain excess fluid from the brain, before leaving the hospital.

While the trial is still small and focused on short-term safety, it marks a major milestone. Further observation will show how well the children move and grow over time. Even so, the results point to a future where spinal repair before birth may offer better long-term outcomes than surgery after delivery.

A New Era in Prenatal Medicine

Advances in prenatal imaging, such as detailed ultrasound and fetal MRI, now allow earlier detection of structural problems. Genetic and chemical tests can also identify certain inherited or developmental disorders before birth. Early detection opens new intervention options long before damage becomes permanent.

In the past, prenatal diagnosis served mainly to prepare for care after delivery. Today, it can lead to treatment inside the womb. For spina bifida, that means early spinal repair enhanced by stem cells. For other conditions, treatments may include enzyme replacement, gene correction or medication delivered through the placenta or amniotic fluid.

Looking Ahead

The ability to diagnose and treat conditions before birth is transforming prenatal care. Complex disorders that once required lifelong management may soon be addressed months earlier. This leads to healthier starts for newborns.

Important questions remain about timing, safety and access. Still, the direction is clear. Treatment before birth offers the best chance to protect developing organs and prevent complications that shape the rest of life. Healing spina bifida in the womb is one clear example of this change. What began as an effort to protect the spine before birth may soon help prevent many other conditions.

Read Dr. Haseltine's latest piece with

Forbes

© William A. Haseltine, PhD. All Rights Reserved.